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Abstract
Background: Central neuropathic pain has a prevalence of 40 % in patients with spinal cord injury.
Electroencephalography (EEG) studies showed that this type of pain has identifiable signatures, that could
potentially be targeted by a neuromodulation therapy. The aim of the study was to investigate the putative
mechanism of neurofeedback training on central neuropathic pain and its underlying brain signatures in
patients with chronic paraplegia.
Methods: Patients’ EEG activity was modulated from the sensory-motor cortex, electrode location C3/Cz/C4/P4
in up to 40 training sessions Results. Six out of seven patients reported immediate reduction of pain during
neurofeedback training. Best results were achieved with suppressing Ɵ and higher β (20–30 Hz) power and
reinforcing α power at C4. Four patients reported clinically significant long-term reduction of pain (>30 %)
which lasted at least a month beyond the therapy. EEG during neurofeedback revealed a wide spread
modulation of power in all three frequency bands accompanied with changes in the coherence most notable
in the beta band. The standardized low resolution electromagnetic tomography analysis of EEG before and after
neurofeedback therapy showed the statistically significant reduction of power in beta frequency band in all
tested patients. Areas with reduced power included the Dorsolateral Prefrontal Cortex, the Anterior Cingulate
Cortex and the Insular Cortex.
Conclusions: Neurofeedback training produces both immediate and longer term reduction of central
neuropathic pain that is accompanied with a measurable short and long term modulation of cortical activity.
Controlled trials are required to confirm the efficacy of this neurofeedback protocol on treatment of pain. The
study is a registered UKCRN clinical trial Nr 9824.
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Background
Central neuropathic pain (CNP) is caused by an injury
to the somato-sensory system with a high prevalence in
amputation [1], spinal cord injury [2], multiple sclerosis
[3], Parkinson disease [4] and stroke [5]. CNP symp-
toms do not respond well to medications and the drugs
used to treat this type of pain are often associated with
significant adverse effects [6]. This has generated interest
in nonpharmacological treatments based on neuromodula-
tion and neurostimulation, such as hypnosis, meditation,
neurofeedback [7], repetitive Transcranial Magnetic Stimu-
lation (rTMS) and transcranial Direct Current Stimulation
(tDCS) [8, 9].
Neuroimagining studies have confirmed that neuromo-
dulation techniques such as hypnosis and meditation, can
globally influence pain matrix [7, 10]. Neurostimulation
techniques such as rTMS and tDCS typically target
primary motor cortex, thereby sending inhibitory signals
directly to thalamus and reducing the perceived sensation
of pain [11].
Neurofeedback is a type of biofeeback in which patients
are provided information about their brain activity in a
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visual or auditory form. It is believed that neurofeed-
back facilitates global brain connectivity and leads to
neuroplasticity [12].
Neurofeedback has been used for treatment of chronic
pain, such as complex regional pain syndrome [13],
fibromyalgia [14], migraine [15]. Neurofeedback studies
for treatment of CNP are inconclusive with respect to
the optimal training protocol [16], most likely due to the
small number of treatment sessions. Most neurofeed-
back protocols for chronic pain target the temporal or
central area of the cortex, up-regulating EEG activity in
the lower β or α band and down-regulating the activity
in the Ɵ and higher β band [13–16]. Based on feedback
information patients can be trained to voluntarily de-
crease brain activity thought to be associated with pain
processing.
During neurofeedback for treatment of chronic pain,
EEG is typically measured at the training site only, pro-
viding no evidences of global modulation of EEG during
training. Likewise, there is also the lack of evidence
whether prolonged neurofeedback treatment produced
long-term changes in cortical activity.
Previous research studies have shown that CNP affects
resting state EEG causing increase in theta power and
the shift of dominant alpha frequency towards the lower
range [17, 18]. Several fMRI studies have shown a correl-
ation between CNP and reorganisation of the sensory
and motor cortex [19, 20], where, due to sensory loss
caused by the injury, the affected cortical somatotopy
undergoes re-mapping or reorganisation [20]. Further-
more, fMRI studies showed that during motor imagery
patients with pain activate both brain areas related to
control of movement and to pain processing [21].
In a recent study of our group [22] we showed that
CNP not only modulates the resting state EEG but also
affects the evoked response over the sensory-motor cor-
tex during imagined movement of ‘painful’ as well as
non-painful limbs in Ɵ, α and β frequency range. Para-
plegic patients with CNP had stronger EEG responses
during imagined movement than paraplegic patients
with no pain and able-bodied people. All of these studies
indicate a close relation between the existence of CNP
and ‘over activation’ of the sensory-motor cortex.
We therefore hypothesize that similar to rTMS and
tDCS, neurofeedback can target the motor cortex, resulting
in normalization of evoked responses and reduction of
CNP. We propose neurofeedback training for treatment of
CNP in chronic paraplegic patients setting three objectives:
(I) Testing the immediate and longer term effect of
neurofeedback training on CNP,
(II)Understanding the putative mechanism through
which neurofeedback induces wide-spread changes
of EEG activity during neurofeedback training,
(III)Assessing the long term effect of training on all
cortical structures involved in processing of pain.
Methods
Patients
Seven chronic patients with paraplegia (age 50 ± 4, 6 males,
1 female) having CNP under the level of injury were re-
cruited for the study from a cohort of 10 patients recruited
for our previous study [22]. The neurological level of Spinal
Cord Injury (SCI) was determined using the American
Spinal Injury Association (ASIA) Impairment Classification
[23]. Inclusion criteria were: paraplegia at level T1 or lower,
at least one year post-injury, a treatment history of CNP
for at least 6 months and a report of pain level ≥ 5 on the
Visual Numerical Scale (0 = no pain, 10 =worst pain im-
aginable). The general exclusion criteria were: presence of
any chronic (non CNP) or acute pain at the time of the ex-
periment; brain injury or other known neurological condi-
tion. Patients receiving pharmacological treatment were
instructed not to change medications during the neuro-
feedback therapy. Information about patients is provided
in Table 1.
At the beginning and at the end of the study patients
filled out the Brief Pain Inventory [24]. Prior to the study
they filled out a 7 Point Guy/Farrar Global Impression of
Change [25] to test whether pain intensity was stable over
the past week. Ethical approval was obtained from the
West of Scotland National Health Service for the Greater
Glasgow and Clyde Ethical Committee. Informed consent
for participation and publication of the study was obtained
from the participants. The procedures followed were in
accordance with the Helsinki Declaration, Ethical princi-
ples for medical research involving human subjects.
EEG recording
During neurofeedback training patient’s EEG was re-
corded using 16 channel Usbamp, (Guger technologies,
Austria). Sampling frequency was 256 Hz and electrode
impedances were below 5 kΩ. The neurofeedback treat-
ment was provided from one electrode at the time but
up to 16 electrodes (F3, Fz, F4, T7, C3, Cz, C4, T8, Cp3,
CPz, C4, P4, P3, O1, Oz and O2) were recorded simultan-
eously. The ground electrode was placed on the mastoid
on the training side and the reference electrode was
placed on the opposite side.
Multichannel EEG recording for off-line analysis was
performed before the first training day and after the last
training day, from 61 channels (Synamp2, Neuroscan,
USA) with electrodes placed according to standard 10/
10 locations [26] using an ear-linked reference and AFz
as ground. Sampling frequency was 250 Hz and imped-
ance was kept below 5 kΩ.
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Real-time data acquisition and analysis
Real time data acquisition and processing was performed
with g.RTanalyzer (Guger technologies, Austria) in Simu-
link, Matlab (Mathworks, USA). A graphical user interface
was developed in LabView (National Instruments, USA).
To calculate EEG power in selected frequency bands,
EEG of each channel was bandpass filtered (5th order IIR
Butterworth) in the selected bands and was then squared
and smoothed/averaged over a half second sliding win-
dow, updated after each sample, to obtain the bandpower
features.
Neurofeedback protocol
A daily neurofeedback session started and finished with
measuring the baseline EEG activity for 2 min in relaxed
open eyes and in closed eyes state. One daily neurofeed-
back training session consisted of 2 sub-sessions with an
audio feedback followed by 6–7 sub-sessions with a
visual feedback. Each sub-session lasted 5 min.
Training started with an audio neurofeedback pro-
vided from the occipital region (Oz) with patients having
their eyes closed, for relaxation purposes. Training pa-
rameters were calculated in the lower α band (7–10 Hz)
at Oz to account for lower peak frequency in patients
with CNP [17, 18, 22]. A relative power was calculated
with respect to 2–30 Hz band. Patients were trained to
increase the α band power with a threshold set at 110 %
of the baseline value. Patients listened to relaxing music,
which had two levels: quieter when the α power was
above a set threshold and louder when the α power was
under the threshold.
Following the audio training patients were provided
with a visual neurofeedback as a therapy to reduce pain.
EEG power was calculated in θ (4–8 Hz), α (9–12 Hz),
lower β (12–15 Hz) and higher β (20–30) Hz bands. The
higher β will be referred as β further in the text and 12–
15 Hz will be called the Sensory Motor Rhythm (SMR).
Relative power was calculated with respect to 2–30 Hz
band.
Contingencies were set such that increases in the α or
SMR and decreases in the Ɵ and β were reinforced. In-
creased Ɵ band power was found positively related to the
presence of CNP [17, 18, 22, 27] and was confirmed in
this particular group of patients [22]. The β band power
was suppressed because these oscillations are thought to
be positively associated with pain [17]. We trained pa-
tients to increase either the SMR or α power because
they showed promising results in some previous neuro-
feedback studies on chronic pain including CNP [16, 28].
The group of patients included in the study had the
dominant α frequency on average 1 Hz lower than pa-
tients with no CNP [22]. Therefore we trained patients
to reinforce the energy of EEG signal in a slightly higher
α band (9–12 Hz) which does not include lowest α band
frequencies at 8Hz. We set the training ‘threshold’ to
110 % of the average power in the α/SMR band and to
90 % of the average power in the Ɵ and β band. Training
was provided from the electrodes located over the pri-
mary motor and sensory cortex C4/C3/Cz/ P4, one
electrode at the time, order as shown in Fig 2. These
electrodes were also a preferred stimulation site for rTMS
and tDCS [8, 29]. In addition, this group of patients had
an ‘overactive’ sensory-motor cortex during a motor im-
agery task [22] so neurofeedback provided from that area
could potentially down-regulate the excessive activity.
During training patients sat in front of a computer
screen that showed three bars, the size of which corre-
sponded to the relative EEG power in three chosen fre-
quency bands (Fig. 1). The bars had green colors when
the power of a representative frequency band was in the
reinforced range and had red color otherwise. The bar in
the middle presented a frequency band that had to be
rewarded (increased) and turned green when the power
was 110 % above the baseline value. Two sidebars
presented two frequency bands that had to be inhibited
(decreased) and turned green when the power was under
90 % of the baseline value. Patients were instructed to
relax and to ‘apply whichever mental strategy they prefer
to make the bars green’.
We tested four protocols: Protocol 1 rewarded SMR and
inhibited Ɵ and β at Cz,. Protocol 2 rewarded α and inhib-
ited Ɵ and β at P4; Protocol 3 rewarded α and inhibited Ɵ
and β at C3. Protocol 4 rewarded α and inhibited Ɵ and β
at C4.
To test for the placebo effect a) patients were shown
data from a pre-recorded neurofeedback session, b) they
were provided with a visual neurofeedback training to
reinforce the α activity at Oz with eyes open; Oz is located
at the occipital area, normally not associated with pain.
Table 1 Information about patients and outcome results of the
neurofeedback therapy
Patient Level of
injury/ASIA
Years with
injury/pain
Location of
pain
Sensation
of pain
Medication
P1 T8 A 7/7 abdomen,
legs,
buttock, fee
pricking,
stabbing
G
P2 T7 A 7/7 shanks, feet burning P
P3 T6/T7 D 9/9 legs, feet Pricking,
stabbing
P
P4 T6/T7 B 25/24 Abdomen,
legs,
buttock,
feet
Squeezing,
stabbing
P
P5 T8 B 9/9 Buttock,
legs, feet
Burning,
stabbing
P
P6 T5/6 A 11/11 Left leg and
foot
burning G
P7 T12 B 33/4 Legs, feet Tingling p
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Assessment sessions
Resting state EEG was recorded with 61 channels under
the open eyes and closed eyes condition in a quiet room.
The resting state EEG was recorded for 2 min for each
condition repeated 3 times, alternating between the con-
ditions. Assessment sessions were performed twice, up
to a week before the first neurofeedback session and up
to a week after the last neurofeedback sessions but never
on a day of neurofeedback training. Post neurofeedback
assessment was performed for patients who had 20 or
more neurofeedback sessions.
EEG off-line analysis
EEG recorded during neurofeedback training was visually
inspected and sections containing blinking, muscle activity
or amplitude over 100 μV were removed, leaving a mini-
mum of 3 min recording. A power spectral density (PSD)
was calculated using Hamming windows over 4 s long
recording overlapped for 2 s. Logarithmic PSD was calcu-
lated as 10∙log10PSD for normalization purposes. For each
frequency, the unpaired t-test was performed to compare
between two conditions and Holms-Bonferroni correction
was applied to reduce the Type I error due to multiple
comparisons.
To calculate changes in connectivity during a training
session compared to the baseline, coherence was calcu-
lated for each channel pair for 4 s long EEG epochs.
The average coherence value was calculated for a chosen
frequency band. The same statistical analysis was used as
for PSD.
Linear regression analysis Y =K1 +K2 ⋅X was performed
to find the best fit curve between the pain intensity and
the number of training sessions using the parametric
Pearson test.
For 61 channel off-line EEG analysis, data were re-
referenced to the average reference. Noise was removed
as described above. The current source density was
calculated for 4 s long epochs in the Ɵ, α and β band.
Localisation of the cortical three-dimensional distribu-
tion of the current density of EEG was performed using
the Standardised Low Resolution Electromagnetic Tom-
ography sLORETA [30]. The sLORETA method has
been shown to have no localization bias [31]. The sLOR-
ETA cortical map/image was computed for 6239 voxel
partitions of intracerebral volume at 5 mm spatial reso-
lution. Brodmann areas are reported using the Montreal
Neurological Institute (MNI) space with correction to
the Talairach Space.
For a group level comparison, data of each patient were
normalised prior to averaging. A paired t-test was applied
to find a statistically significant difference between EEG
before and after the therapy. A 5000 voxel randomization
of statistical non-parametric mapping [32] implemented
in sLORETA package was used to calculate a corrected
critical thresholds and p-values.
Results
Five out of seven patients with pain (P1-5) completed
the study. Two patients withdrew after 3 sessions, one
because of problems with transportation, although ex-
periencing reduction of pain (P 6) and the other because
Fig. 1 A graphical user interface used for neurofeedback training. Horizontal black lines show threshold values. Central bar shows power of the
dominant frequency band, which had green colour when it was reinforced, I,.e. when the power was above the threshold. Side bars present theta
(left) and beta (right) frequency bands that were supressed. They had green colour when the power was under the threshold, otherwise were red
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of the lack of response (P7). Four patients received 40
treatment sessions and the fifth patient, who stayed at
the hospital for the purpose of the study, received 20
sessions. Patients who travelled from their homes re-
ceived 1–3 sessions per week while the patient who
stayed at the hospital received five sessions per week.
None of patients reported reduction of pain during
training with Protocol 1. Patients P2 and P4 reported
the moderate reduction of pain as a result of training
with Protocol 2. Both Protocols 3 and 4 resulted in a
substantial reduction of pain, going down to 0–2 on the
visual numerical scale during training. However, patients
P3-5 reported strong spasm during training with Proto-
col 3, which manifested as uncontrollable movements of
their paralyzed legs while sitting in front of the com-
puter screen practicing neurofeedback. Patients were
trained with Protocol 4 on most of training days as it
provided best relief from pain with minimum side ef-
fects. Fig. 2 shows the number of sessions and sequence
of training for each protocol. The order of protocol was
not identical for each patient and depended on their
response (no reduction of pain, spasm, etc.).One some
days patients were trained with two protocols (3 succes-
sive, 5 min long sub-sessions with each protocol). For
each training protocol a patient was initially trained for
at least two days in a raw, to allow some time to learn
neurofeedback strategy for each protocol. Though Proto-
col 4 seemed to achieve best reduction of pain, other
protocols were occasionally re-tested to test whether pa-
tients responded in a consistent way. Note that there
was no established successful protocol for treatment of
CNP, so having an initial hypothesis that the sensory-
motor area is overactive in CNP [21, 22] we tested dif-
ferent location over that area of the cortex, keeping
similar training parameters. Initial testing of different lo-
cation is a standard practice in creating a novel neuro-
feedback protocol [13, 16].
The effect of placebo training was tested on two days,
between 10th and 20th training day. The effect of mental
rehearsal of neurofeedback was tested within the last 5
training days.
The effect of neurofeedback training on the intensity of
pain
Six out of seven patients reported the immediate reduc-
tion of pain already during 2nd or 3rd daily treatment.
Initially however that reduction was short-term, during
neurofeedback. All five patients who received 20 or
more treatment sessions achieved a statistically significant
reduction of pain, being clinically significant (>30 % of the
individual initial pain intensity as defined by a Visual nu-
merical scale) in four patients (Table 2). The long-term re-
duction of pain (which lasted beyond the neurofeedback
treatment) in all patients was gradual and lasted for sev-
eral weeks after termination of the therapy. Patients were
contacted about one month after the end of the treat-
ment, they still had reduced intensity of pain but it
increased 1–2 grades of Visual numerical scale as com-
pared to last neurofeedback session. A linear regression
analysis showed a significant negative correlation be-
tween the intensity of pain and the number of training
sessions (P1: r = 0.74, p = 0.023, P2: r = 0.66, p = 2.5 · 10−5;
P3: r = 0.61, p = 0.001; P4: r = 0.83, p = 6.85 · 10−8; P5: r =
0.64, p = 0.005).
Two patients who before treatment suffered from spas-
ticity/clonus (P3) and spasm/tightness (P4) reported the
reduction of this symptoms on the days of training. All pa-
tients who experienced the reduction of pain, including
patients with the complete loss of sensation, reported the
pleasant sensation of warmth in their legs which preceded
pain relief and lasted for several hours.
Patients P2-5 were able to self-regulate their brain activ-
ity between treatment sessions (documented by EEG re-
cordings) which helped reducing their pain. An example
for P3 is shown in Fig 3b. However they gradually lost that
ability a month after the last session due to the lack of a
proper visual association.
Fig. 2 The number of sessions and sequence of training for each protocol
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EEG modulation during training at the training site
Figure 3a-e show the logarithmic PSD in patients P1-5
before, during and after training on one representative
training sub-session lasting 5 min. Patients were able to
selectively reinforce or suppress power in different fre-
quency bands, though only P5 modulated power of all
three frequency bands simultaneously in a desired direc-
tion. It can be noticed that the effect of training on EEG
power still remains in the first few minutes following the
training (‘Post NF’). Pannel labeled with PWP1 at the
bottom corresponds to PSD in patient 1. Consequtive
pannels labeled with PWP2,3,4 and 5 corresponds to pa-
tients 2,3,4 and 5 respectivly.
Figure 4a shows PSD before training (‘Pre NF’), during
real training (‘NF’) and during placebo training (‘Placebo’)
with a pre-recorded session in P5. PSD during placebo
training was not significantly different from PSD before
training and no reduction of pain was reported. During
placebo training with a feedback provided from the elec-
trode location Oz patents unsuccessfully tried to reinforce
the α band power (as the occipital alpha normally de-
creases during visual attention) and did not report any re-
duction of pain. It should be however mentioned that
during a neurofeedback training with closed eyes patients
successfully increased their occipital α but none of the pa-
tients reported the reduction of pain.
Figure 4b shows PSD in P5 before training (‘Pre NF’),
during training with a visual feedback (‘NF’) and during
mental neurofeedback practice (‘Practice’) without the
visual feedback. The patient regulated EEG power in
the same direction and in the same frequency band in
the α and β range during the training with feedback
and during the mental practice. Four patients P2-5
were able to modulate their PSD during mental neuro-
feedback practice.
Global EEG modulation during neurofeedback training
Figure 5 shows scalp maps of PSD over three frequency
bands before and during training provided at C4 with
protocol 4. Frontal Ɵ was suppressed during training in all
five patients. This Ɵ band suppression is likely to be a
consequence of voluntary modulation, because increased
Table 2 Information about the outcome of the neurofeedback
therapy
Patient Pain before therapy
(VNS)
Pain following therapy
(VNS)
Number of
sessions
P1 6 5 40
P2 7 5 40
P3 6 2 40
P4 9 6 40
P5 9 6 20
P6 8 6 3
P7 6 6 3
Fig. 3 Neurofeedback training with Protocol 4 in P1-5, EEG power as a function of frequency recorded at C4. EEG power at the baseline (‘Pre NF’),
during neurofeedback training (‘NF’) and 2–3 minutes following training (‘Post NF’). Bars above graphs show three frequency bands in which training
was provided. Arrows up marks a band that was reinforced while arrows down mark frequency bands which were suppressed. Black bars under graphs
show statistically significant difference for ‘NF’-‘Pre NF’, while grey bars show statistically significant difference for ‘Post NF’-‘Pre NF’
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concentration due to nonspecific engagement in a mental
task should result in increased frontal Ɵ [33].
In the α range, training resulted in the increase of power
over the central cortex, on both contra and ipsilateral site
in P1,2,4 5 while in P3 training resulted in the shift of a
maximum α power from the occipital to the central re-
gion. In general, the α rhythm characterizes the idle state,
and simply focusing attention on object on a computer
screen should therefore result in decrease of α power. A
wide-spread increase of α power during neurofeedback
training could therefore be attributed to the voluntary
modulation of brain activity rather than to the general
increase of attention. A wide spread increase in the α
power can be partially explained by the volume conduc-
tion effect, spreading the α activity from the training site
at C4. However in P1 and P2 the α power increased more
on the contra than on the ipsilateral site of training and in
P3 the maximum of α activity shifted from the occipital to
the central area.
In four patients (P2-P5) the suppression of the frontal
β (20–30 Hz) can be noticed during training, being
stronger than suppression at the training site.
Figure 6 shows the location of electrodes with statistically
significant differences in PSD between the neurofeedback
Fig. 4 The effect of (a) placebo training and (b) of mental practice with no visual feedback. Graphs present EEG power as a function of frequency
recorded at C4 for both conditions. Fig. 4a shows EEG power in patient P5 during neurofeedback training (‘NF’), placebo training (‘Placebo’) and
pre-training baseline (‘Pre NG’), Fig. 4b shows EEG power in patient P5 during neurofeedback (‘NF’), mental practice without a feedback (‘Practice’)
and pre-training baseline (‘Pre NF’). Black bars under graphs a and b show statistically significant differences for ‘NF’-‘Pre NF’, while grey bars show
statistically significant difference for ‘Pre NF’-‘Placebo’ in (a) and for ‘Pre NF’-‘Practice’ in (b)
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and the pre-training baseline (PSD neurofeedback- PSD
baseline). All patients had a significantly decreased Ɵ band
power in the frontal region that in P4 was accompanied
with a power increase in the rest of the cortex. All patients
had at least one location in the central area of the cortex
where the α power significantly increased during training.
Four patients (P2-P5) had a significant decrease of β band
power in the central and frontal areas. In P2 the decrease
of β band power was global and in P1 there was a signifi-
cant increase of the central and frontal β band power.
Figure 7 shows statistically significant difference in co-
herence (coherence baseline- coherence training) be-
tween different cortical regions, in the Ɵ, α and β band
(p = 0.05). In the Ɵ band a large decrease in coherence
between the occipital and central, occipital and frontal,
and central and frontal regions can be noticed only in P
3. In the α band, coherence increased between the oc-
cipital and central and the occipital and frontal region in
P1 and P4 while in P 5 coherence decreased between the
occipital and central region and increased between the
central and frontal region. Largest changes in coherence
in all five patients were noticed in the β band. In all five
patients the coherence decreased between the occipital
and central region; in P1,2,4,5 it also decreased between
the occipital and frontal areas. In three patients P1,3,5
the interhemispheric coherence increased within the
central region.
Long-term effect of neurofeedback training
A multichannel EEG (61 channles) in a relaxed state was
analyzed in the Ɵ, α and β frequency ranges. Statistically
significant changes on a group level were noticed in the β
band only where reduced activity was noticed in several
pain related areas (Table 3). Strongest changes (expressed
as the percentage of the total number of voxels) were
noticed in the dorso-lateral prefrontal cortex, anterior cin-
gulate cortex and the insular cortex. Fig. 7 shows the
Fig. 5 The influence of neurofeedback training with protocol 4 at C4 on wide spread EEG power in different frequency bands. Scalp maps during
training (‘NF’) and before training (‘PreNF’) in Ɵ, α and β frequency bands. Location of C4 is shown with black dots in P1 scalp maps. P1-5: patients
1–5. Units on side bar graphs μV2
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Fig. 6 Location of electrodes with significant difference in power (‘NF’—‘PreNF’) shown in Fig 5. Dark circles indicate power increase while grey
circles indicate power decrease
Fig. 7 Scalp maps showing statistically significant changes in EEG coherence between 16 scalp sites during training compared to baseline before
training (neurofeedback training-baseline) for each patient in three frequency bands (a) Theta band, (b) Alpha band (c) Beta band (significance
level p = 0.05, corrected for multiple comparison). Training provided with protocol 4 at C4, marked with a black dot in the upper left figure. The
same EEG data used to create EEG power scalp maps in Fig. 5. Solid lines show increase in coherence and dotted lines show decrease in coherence
during neurofeedback as compared to the baseline. The thickness of line shows strength of change in coherence (thin line: 0 to 0.1, medium line: 0.1
to 0.2, thick line: 0.2 to onwards)
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reduction of β activity over the surface areas of the cortex
(Fig. 8a) and several deeper cortical structures (Fig. 8b-d).
On the individual level, P1 had a significantly reduced
activation in the Ɵ band at the primary sensory and
motor cortices and the posterior parietal cortex and P2,
P4 and P5 had significantly increased α activity over the
primary sensory and motor cortices and over all cortical
structures reported in table 3. Patient P3, on the con-
trary, had a significant decrease in the α activity.
Discussion
This paper presents the effect of neurofeedback training
on reduction of CNP and on related neurological mea-
sures. Using a visual feedback, patients learned how to
modulate their brain activity in a desired directions
which resulted in reduction of pain.
Six out of seven tested patients achieved short-term im-
mediate reduction of pain during neurofeedback training.
To achieve longer lasting reduction of pain repeated
neurofeedback sessions were required. Four out of five
patients who received a long term training achieved a clin-
ically relevant reduction of pain (>30 %) lasting at least a
month following the treatment. A negative correlation be-
tween the intensity of pain and the number of training
sessions indicate that the long-term reduction of pain was
gradual and required long training. All patients experi-
enced the reduction of pain while receiving a neurofeed-
back training from electrodes located above the primary
motor cortex (C3/C4), which was also a preferred stimula-
tion site for rTMS and tDCS [29, 34]. In Jensen’s et al.,[16]
neurofeedback study for treatment of CNP, 10–15 Hz
band was reinforced at C3 and C4 while α band was rein-
forced at T7/T8 with a moderate (not clinically signifi-
cant) reduction of pain. Better patients’ response in our
study might be due to different combination of frequency
bands and electrode location (primary motor cortex of
legs and arms) or due to the larger number of training
sessions, as a prolonged effect of neurofeedback gradually
increased over the 40 sessions.
Volunteers from our study that achieved the clinically
significant reduction of pain reinforced the α power and
to some extent suppressed the β power during training.
Although the Ɵ band power is believed to be the signature
of CNP [17], the only patient who successfully suppressed
the Ɵ rhythm experienced least reduction of pain. This
might be related to the fact that patients received medica-
tions known to increase the Ɵ band power [35].
Although neurofeedback was dominantly practiced
from the right side of the central cortex at C4, patients
reported reduction of pain in their legs, confirming
Table 3 Percentage of voxels in pain related brain areas
showing the average reduced activation
Cortical Areas BAs Voxels (%) Maximum
activation
MNI coordinates
with maximum value
S1 1,2,3 NS / / / /
S2 40,43 NS / / / /
M1 4 NS / / / /
PMC 6 2 −0.97 −15 25 40
SMC 8 4 −0.96 −20 30 45
DLPC 9,46 30 −0.99 −15 40 25
APFC 10,11 4 −0.96 −20 45 30
PPC 5,7 / / / / /
ACC 24,32 20 −0.99 −15 35 20
PCC 23,31 NS / / / /
IC 13 24 −1.01 −30 15 15
-0.5
-1
1
0.5
0(a) (b)
(c) (d)
Fig. 8 Changes in activity in eyes open state in the β band before the first and after the last day of neurofeedback training (After-Before) averaged
over five patients P1-5. (a) Surface maps (top, left, right and frontal), (b) BA 13 [MNI coordinate: −30 15 15, t = −1.01], (c) BA32 [MNI coordinate: −15 35
20, t = −0.99], (d) BA 24 [MNI coordinate: −5 25 15, t = −0.99]. Blue colour correspond to reduced activity
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observations from rTMS studies that the exact somato-
topical location of stimuli is less relevant [36].
Because patients were occasionally trained with dif-
ferent protocols, one cannot claim that training specif-
ically at C4 produced long-term changes. However all
protocols involved sensory-motor area and were based
on decreasing theta and higher beta band and increas-
ing alpha or lower beta band. In addition, training at
one electrode caused wide spread changes so one can
assume that all training protocols globally affected
sensory-motor cortex, though they caused to some ex-
tend different physical responses. In this study, a multi-
channel EEG was recorded only during training from
C4 (Protocol 4). In the future, it would be interesting to
compare global effect of training from the electrode lo-
cations included in the training protocols (P1-P3).
It is believed that chronic pain disrupts ‘a default
mode network’ [37]. Neurofeedback training was accom-
panied by changes in coherence between occipital and
central and occipital and frontal cortex, most notably in
the β band. Similar changes in connectivity during hyp-
nosis were attributed to the disruption of pain matrix,
possibly establishing a normalized default mode network
[7] The higher beta band (20–30 Hz) was the only fre-
quency band in which long-term changes were noticed
in all participants. Largest changes occurred in the β
band of the dorsolateral prefrontal cortex, the cingulate
cortex and the insular cortex. The former is related to
the cognitive aspect of pain while two later are parts of
the limbic system and deal with the emotional aspect of
pain [38]. Previous studies showed that chronic pain
shifts brain representation from the nociceptive to the
emotional circuits [39], therefore reduction of chronic
pain might be first manifested in cortical structures
regulating the emotional aspect of pain.
This study tested neurofeedback protocols from the pri-
mary motor cortex which is not the part of the standard
pain matrix [38]. It is possible that this neurofeedback
Protocol 4 is specific to CNP and that it would not be effi-
cient for other types of chronic pain. One of the protocols
in this study involved sensory cortex (P4, Protocol 2) but
patients reported less reduction of pain than with neuro-
feedback from C3 and C4. It was difficult to assess how
neurofeedback practice with one protocol influenced learn-
ing new protocol, though empirically we had impression
that it helped, in particular because electrodes were chosen
from functionally the same area of the brain. It is hard to
measure with EEG the activity of other cortical areas in-
volved in processing of chronic pain but a single daily ses-
sion fMRI neurofeedback study reported reduced CNP in
patients trained to regulate the activity of the anterior cin-
gulate cortex [40].
A perceived sensation of pleasant warmth reported
by all patients, including these with a complete loss of
sensation, might be an indicator of indirect activation
of corresponding thalamic nuclei, being in a close prox-
imity to pain nuclei [41]. Alternatively, it may support
the theory of CNP representing a thermoregulatory
dysfunction [42].
The ability to ‘self-administer’ therapy i.e. to modulate
their brain activity at will without a visual feedback was
achieved by 4 out of 5 patients; this ability was previ-
ously reported by patients practicing mindfulness and
hypnosis [43, 44]. This is a very important observation
because CNP in this patients was caused by paralysis
and as such can be more or less effectively ameliorated
but not cured. Patients ability to self-regulate brain ac-
tivity on demand would be an important prerequisite for
keeping pain under control in long term.
Although some patients reported spasm during train-
ing, in two patients this resulted in reduced tightness
and clonic activity following neurofeedback. It is be-
lieved that sensory-motor cortex is one of the sites from
which it is possible to modulate monosynaptic reflexes
[45] that might be related to spasm observed in two pa-
tients. Previously rTMS stimulation of the primary
motor cortex was shown to reduce spasm [46] indicating
possible similarities between neuromodulatory mechan-
ism of neurofeedback from sensory-motor cortex and
rTMS. To fully understand the potential of the mechan-
ism of neurofeedback treatment, further randomized
controlled study is required.
Conclusions
The results of the study show that prolonged neuro-
feedback training may have a potential to reduce CNP.
Neurofeedback training affects deeper cortical struc-
tures involved in processing of chronic pain. We tested
neurofeedback treatment on patients who had long-
standing CNP. The effect of neurofeedback might be
better on patients who suffered from CNP for a shorter
period of time, as prolonged pain might cause long
lasting changes in brain connectivity 19]. Larger con-
trolled trial would be needed to confirm this results
before it could be recommended as a neurofeedback
training protocol for CNP.
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